StreetInsider.com News Articles

StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 24 Apr 2026 08:16:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Made-in-China.com and the Uzbekistan Business Diplomacy Association Launch Green Manufacturing Initiative on Earth Day http://www.streetinsider.com/Press+Releases/Made-in-China.com+and+the+Uzbekistan+Business+Diplomacy+Association+Launch+Green+Manufacturing+Initiative+on+Earth+Day/26362583.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/uz..tashkt" idsrc="xmltag.org" >TASHKENT, Uzbekistan</location></span>, <span class="legendSpanClass"><chron>April 24, 2026</chron></span> /PRNewswire/ -- On the 57th anniversary of Earth Day, Made-in-China.com, a leading comprehensive service platform for global cross-border trade, officially launched the "Green Commitment • Across the <location>Silk Road</location>" initiative in <location value="LU/uz..tashkt" idsrc="xmltag.org" >Tashkent</location>. This strategic event, held in partnership with the <span>Uzbekistan Business Diplomacy Association</span> (O'zbekiston biznes diplomatiyasi uyushmasi) and representatives of Chinese enterprises, represents a step toward expanding sustainable manufacturing into global markets.</p> <p><b>Overview of the "Green Commitment • Across the <location>Silk Road</location>" initiative</b></p><p>The initiative is a collaborative program involving a B2B platform, an industry association and exporters. http://www.streetinsider.com/Press+Releases/Made-in-China.com+and+the+Uzbekistan+Business+Diplomacy+Association+Launch+Green+Manufacturing+Initiative+on+Earth+Day/26362583.html Fri, 24 Apr 2026 08:16:00 -0400 MEE Made-in-China.com and the Uzbekistan Business Diplomacy Association Launch Green Manufacturing Initiative on Earth Day http://www.streetinsider.com/PRNewswire/Made-in-China.com+and+the+Uzbekistan+Business+Diplomacy+Association+Launch+Green+Manufacturing+Initiative+on+Earth+Day/26362583.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/uz..tashkt" idsrc="xmltag.org" >TASHKENT, Uzbekistan</location></span>, <span class="legendSpanClass"><chron>April 24, 2026</chron></span> /PRNewswire/ -- On the 57th anniversary of Earth Day, Made-in-China.com, a leading comprehensive service platform for global cross-border trade, officially launched the "Green Commitment • Across the <location>Silk Road</location>" initiative in <location value="LU/uz..tashkt" idsrc="xmltag.org" >Tashkent</location>. This strategic event, held in partnership with the <span>Uzbekistan Business Diplomacy Association</span> (O'zbekiston biznes diplomatiyasi uyushmasi) and representatives of Chinese enterprises, represents a step toward expanding sustainable manufacturing into global markets.</p> <p><b>Overview of the "Green Commitment • Across the <location>Silk Road</location>" initiative</b></p><p>The initiative is a collaborative program involving a B2B platform, an industry association and exporters. http://www.streetinsider.com/PRNewswire/Made-in-China.com+and+the+Uzbekistan+Business+Diplomacy+Association+Launch+Green+Manufacturing+Initiative+on+Earth+Day/26362583.html Fri, 24 Apr 2026 08:16:00 -0400 MEE PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/Press+Releases/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html <div class="xn-content"> <p>Highlights include:</p> <ul type="disc"><li>Initiated a debt reduction package to strengthen balance sheet</li><li>Re-established critical intellectual property license</li><li>Launched pre-clinical studies to evaluate Promino's efficacy both in cancer patients and muscle retention for those on GLP-1 drugs like Ozempic™</li><li>Significant recapitalization efforts, including a <money>$2.2M</money> equity financing and proposed acquisition of <money>$3 million</money> cash and equivalents of <span>Helios Helium Corp.</span></li></ul><p><span class="legendSpanClass"><location value="LU/ca.on.burltn" idsrc="xmltag.org" >BURLINGTON, ON</location></span>, <span class="legendSpanClass"><chron>June 3, 2024</chron></span> /PRNewswire/ - <span value="Frankfurt:93X" idsrc="xmltag.org" >Promino Nutritional Sciences, Inc.</span> (CSE: MUS) (OTC: MUSLF) (<location value="LU/de..frankf" idsrc="xmltag.org" >FRANKFURT</location>: 93X) ( the "Company" or "Promino") (<a target="_blank" href="https://c212.net/c/link/?t=0&l=en&o=4180798-1&h=2318769437&u=http%3A%2F%2Fwww.drinkpromino.com%2F&a=www.drinkpromino.com" target="_blank" rel="nofollow">www.drinkpromino.com</a>) today provides a corporate update on significant http://www.streetinsider.com/PRNewswire/PROMINO+NUTRITIONAL+SCIENCES+PROVIDES+CORPORATE+UPDATE/23309333.html Mon, 03 Jun 2024 06:00:00 -0400 93X A.21326723 A.60011315 A.60011316 ELMT MEE MUS MUSLF MUSLF O.13395401 O.20297366 O.34405546 O.37916539 O.50651859 POW